Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 4/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 8/20 | 0.47 |
| ▸ | MIF | P14174 | 5/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | BACH1 | O14867 | 1/20 | 0.44 |
| ▸ | MAFK | O60675 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulforaphane SCHEMBL17629812 | 1.00 | NAAA (0.50) | NAAATRPA1MIFKEAP1NFE2L2 | |
| Sulforaphane SCHEMBL105203 | 1.00 | NAAA (0.50) | NAAATRPA1MIFKEAP1NFE2L2 | |
| Sulforaphane SCHEMBL20855320 | 1.00 | NAAA (0.50) | NAAATRPA1MIFKEAP1NFE2L2 | |
| L-Sulforaphane SCHEMBL29370377 | 1.00 | NAAA (0.50) | NAAATRPA1MIFKEAP1NFE2L2 | |
| Sulforaphane SCHEMBL15822685 | 1.00 | NAAA (0.50) | NAAATRPA1MIFKEAP1NFE2L2 | |
| SCHEMBL25332541 | 0.98 | NAAA (0.54) | NAAATRPA1MIFKEAP1NFE2L2 | |
| SCHEMBL1607124 | 0.98 | NAAA (0.54) | NAAATRPA1MIFKEAP1NFE2L2 | |
| SCHEMBL14933784 | 0.98 | NAAA (0.54) | NAAATRPA1MIFKEAP1NFE2L2 | |
| SCHEMBL2485837 | 0.98 | NAAA (0.54) | NAAATRPA1MIFKEAP1NFE2L2 | |
| SCHEMBL106183 | 0.98 | NAAA (0.54) | NAAATRPA1MIFKEAP1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10401 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746880-A2 | METHODS OF TREATING DILATED CARDIOMYOPATHY | Regencor, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122075798-A | Three-dimensional porous bioactive scaffold, vascularized bone organ and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-12635720-B2 | Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids | OMEGA FOODS LLC (US) | 2026-05-26 | — | — | US | claimed |
| CN-122074540-A | Rosemary serving as preservative and extraction process thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260139320-A1 | StarTrace: A Multiplex Drug Testing Platform for Personalized Medicine | UNIV OF SOUTH CAROLINA (US) | 2026-05-21 | — | — | US | claimed |
| CN-122031543-A | A medicinal and edible composition for preventing and improving pulmonary nodule and pulmonary fibrosis, and its preparation method and application | 南京中医药大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122038303-A | Induction system for improving reprogramming efficiency of somatic cells and reprogramming method | 广州医科大学附属第五医院(广州再生医学与健康广东省实验室附属医院) | 2026-05-15 | — | — | CN | claimed |
| US-20260130395-A1 | Water Dispersible Botanical Compositions | AQUILA BLACK LTD (AU) | 2026-05-14 | — | — | US | claimed |
| US-12622857-B2 | Skin lightening composition | Bella Aurora Labs, S.A. (ES) | 2026-05-12 | — | — | US | claimed |
| US-20260124284-A1 | COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MILK THISTLE EXTRACT OR POWDER | NUTRAMAX LAB INC (US) | 2026-05-07 | — | — | US | claimed |
| WO-2002002190-A2 | PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES BY GLUTATHIONE AND PHASE II DETOXIFICATION ENZYMES | JOHNS HOPKINS SCHOOL OF MEDICINE (US) | 2002-01-10 | — | — | WO | claimed |
| WO-2001045661-A2 | COSMETIC AND/OR PHARMACEUTICAL PREPARATIONS | COGNIS FRANCE, S.A. (FR) | 2001-06-28 | — | — | WO | claimed |
| EP-1100517-A1 | NUTRIENT AND THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF CANCER | Kosbab, John V. (US) | 2001-05-23 | — | — | EP | claimed |
| WO-2000045829-A1 | BRASSICA EXTRACTS OR SULFORAPHANE IN COMBINATION WITH RESVERATROL AS ANTITUMOR AGENTS | WASSEN INTERNATIONAL LIMITED (GB) | 2000-08-10 | — | — | WO | claimed |
| US-RE36784-E | Chemoprotective isothiocyanates | THE JOHNS HOPKINS UNIVERSITY (US) | 2000-07-18 | — | — | US | claimed |
| WO-2000007607-A1 | NUTRIENT AND THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF CANCER | KOSBAB, JOHN, V. (US) | 2000-02-17 | — | — | WO | claimed |
| US-5686108-A | Brassica vegetable supplement and process for manufacture | AMWAY CORPORATION (US) | 1997-11-11 | — | — | US | claimed |
| US-5411986-A | Chemoprotective isothiocyanates | THE JOHNS HOPKINS UNIVERSITY (US) | 1995-05-02 | — | — | US | claimed |
| WO-1994019948-A9 | CHEMOPROTECTIVE ISOTHIOCYANATES | — | 1994-11-10 | — | — | WO | claimed |
| WO-1994019948-A1 | CHEMOPROTECTIVE ISOTHIOCYANATES | CHO CHEON GYU (US) | 1994-09-15 | — | — | WO | claimed |